Allianz Asset Management
NUVB icon

Allianz Asset Management’s Nuvation Bio NUVB Stock Holding History

Allianz Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,500
Closed -$166K – 2080
2025
Q4 		$166K Buy
+18,500
New +$115K ﹤0.01% 1946
2023
Q3 		– Sell
-95,136
Closed -$171 – 2241
2023
Q2 		$171 Hold
95,136
– – ﹤0.01% 2120
2023
Q1 		$158K Buy
+95,136
New +$193K ﹤0.01% 2051

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Allianz Asset Management's NUVB Position: Q1 2026 in Review

Allianz Asset Management sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 18,500 shares — an estimated $166K sold.

Allianz Asset Management first reported a position in NUVB in Q1 2023 and held it in 3 quarters. The position peaked at $166K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Allianz Asset Management reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
  • Allianz Asset Management sold 18,500 Nuvation Bio shares in Q1 2026, an estimated $166K.
  • Allianz Asset Management first reported a position in Nuvation Bio in Q1 2023 and held it in 3 quarters.
  • Allianz Asset Management's Nuvation Bio position peaked at $166K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.